Newborn screening for inborn errors of metabolism: a systematic review.
暂无分享,去创建一个
A. Culyer | P. Bower | G. Addison | P. Littlejohns | J. Hewison | B. Dowdeswell | J. Lord | F. Cockburn | R. Chalmers | C. Seymour | M. Bain | M. Thomason | A. Wilcox | M. Bain | J. Farndon | Richard Lilford | I. Russell | C. Clarke | C. Florey | D. Sackett | Theresa M. Marteau | C. Seymour | RA Chalmers | G. Addison | AH Wilcox | David Cohen | John Farndon | A. Wilcox
[1] E. Kaner,et al. General practice postal surveys: a questionnaire too far? , 1996, BMJ.
[2] A. Galloway,et al. Performance of neonatal screening programme must be monitored , 1996, BMJ.
[3] H. Hitzeroth. Familial hypercholesterolemia in South Africa: to screen or not to screen? A national perspective , 1996 .
[4] J. E. Wraith,et al. Histidinaemia: a benign metabolic disorder. , 1996, Archives of disease in childhood.
[5] Millington,et al. Rapid diagnosis of homocystinuria and other hypermethioninemias from newborns' blood spots by tandem mass spectrometry. , 1996, Clinical chemistry.
[6] J. Stevenson,et al. An audit of the organisation of neonatal screening for phenylketonuria and congenital hypothyroidism in the Northern Region. , 1996, Public health.
[7] R. W. Logan,et al. Synthesis and characterisation of acyl glycines. Their measurement in single blood spots by gas chromatography-mass spectrometry to diagnose inborn errors of metabolism. , 1996, Journal of chromatography. B, Biomedical applications.
[8] C. Essex,et al. Neonatal screening in New Zealand , 1996, BMJ.
[9] B. Wilcken,et al. Newborn screening for congenital adrenal hyperplasia: testing to commence in New South Wales. , 1996, Journal of paediatrics and child health.
[10] G. Briand,et al. Direct analysis by electrospray ionization and matrix-assisted laser desorption ionization mass spectrometry of standard and urinary acylcarnitines. Comparison with fast atom bombardment and gas chromatography chemical ionization mass spectrometry , 1995 .
[11] R. West,et al. Overview of newborn screening in Arkansas. , 1995, The Journal of the Arkansas Medical Society.
[12] G. Berry,et al. Endogenous synthesis of galactose in normal men and patients with hereditary galactosaemia , 1995, The Lancet.
[13] H. Simmonds,et al. Screening tests for adenylosuccinase deficiency , 1995 .
[14] S. Waisbren,et al. Cognitive function in early treated biotinidase deficiency: Follow-up of children detected by newborn screening , 1995 .
[15] J. Pinto-Martin,et al. Phenylketonuria screening: effect of early newborn discharge. , 1995, Pediatrics.
[16] M. Rodríguez-González,et al. Neonatal screening for phenylketonuria and congenital hypothyroidism in Principado de Asturias (Spain) using two types of blood samples , 1995 .
[17] T. Coşkun,et al. Neonatal PKU screening in Turkey: 7 years experience in a developing country , 1995 .
[18] D. Webster,et al. The proper role of the international society for neonatal screening (ISNS) in comparisons of newborn screening methodologies , 1995 .
[19] G. Addison,et al. Survey of scope of neonatal screening in the United Kingdom , 1995, BMJ.
[20] K. Widhalm,et al. Screening for biotinidase deficiency in Austria , 1995 .
[21] M. Bucknall,et al. Diagnosis of Inborn Errors of Metabolism from Blood Spots by Acylcarnitines and Amino Acids Profiling Using Automated Electrospray Tandem Mass Spectrometry , 1995, Pediatric Research.
[22] E. Espiner,et al. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens. , 1995, The New Zealand medical journal.
[23] B. No̸rgaard-Pedersen,et al. Improved stability of apolipoproteins A-I and B in filter-paper blood spots impregnated with ascorbic acid. , 1995, Clinical chemistry.
[24] Y. Hase,et al. A new method to detect homocysteine in dried blood spots using thin layer chromatography , 1995 .
[25] H. Levy,et al. Delayed increase in blood phenylalanine concentration in phenylketonuric children initially classified as mild hyperphenylalaninemia , 1995 .
[26] H. Levy,et al. Early newborn specimen: Survey of practices among newborn screening programs in the United States , 1995 .
[27] J. Thompson,et al. DNA analysis for detection of medium-chain acyl-CoA dehydrogenase deficiency in a Manitoba newborn population , 1995 .
[28] E. Hoffman,et al. Medium Chain Acyl-CoA Dehydrogenase Deficiency in Pennsylvania: Neonatal Screening Shows High Incidence and Unexpected Mutation Frequencies , 1995, Pediatric Research.
[29] J. Lavine,et al. Walking the ethical highwire: Genetic screening and hereditary tyrosinemia , 1995, Hepatology.
[30] A. Bergman. Is universal neonatal hemoglobinopathy screening cost-effective? , 1995, Archives of pediatrics & adolescent medicine.
[31] J. Beeso,et al. An Improved Method for the Quantitation of Apolipoprotein B and Apolipoprotein A-1 in Dried Blood Spots , 1995, Annals of clinical biochemistry.
[32] D. Tappin,et al. An audit of infants ‘unscreened’ by the neonatal screening system in Scotland during 1991 , 1995 .
[33] J. Loeber,et al. Phenylketonuria screening using the Quantase phenylalanine kit in combination with a microfilter system and the dye Tartrazine , 1995 .
[34] D. Cox,et al. The Wilson disease gene: spectrum of mutations and their consequences , 1995, Nature Genetics.
[35] J. Leonard,et al. Regional variations in medium-chain acyl-CoA dehydrogenase deficiency , 1995, The Lancet.
[36] T. Tuuminen. Need for guidelines for comparisons and assessments of new methods , 1994 .
[37] K. Widhalm,et al. Long-term follow-up of 58 patients with histidinemia treated with a histidine-restricted diet: no effect of therapy. , 1994, Pediatrics.
[38] D. Rabier,et al. Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemia. , 1994, The Journal of pediatrics.
[39] T. Weber,et al. Analytical quality control in neonatal screening. , 1994, Clinical biochemistry.
[40] H. Levy,et al. Current approaches to genetic metabolic screening in newborns. , 1994, Current opinion in pediatrics.
[41] I. Smith. Treatment of phenylalanine hydroxylase deficiency , 1994, Acta paediatrica (Oslo, Norway : 1992). Supplement.
[42] S. Suwa. Nationwide survey of neonatal mass-screening for congenital adrenal hyperplasia in Japan , 1994 .
[43] Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.
[44] J. Leonard,et al. Clouds still gathering over galactosaemia , 1994, The Lancet.
[45] J. Stevenson,et al. Audit improves neonatal (Guthrie) screening programme , 1994, BMJ.
[46] G. Bickler,et al. Variation in coverage by ethnic group of neonatal (Guthrie) screening programme in south London , 1994, BMJ.
[47] F. Lorey,et al. Effect of specimen collection method on newborn screening for PKU , 1994 .
[48] A. Grüters,et al. Improving the efficacy of newborn screening for congenital adrenal hyperplasia by adjusting the cut-off level of 17α-hydroxyprogesterone to gestational age , 1994 .
[49] R. Guthrie. Screening for PKU with a fluorometric method , 1994 .
[50] B. No̸rgaard-Pedersen. Towards acceptable practices for antenatal and neonatal screening for disease or disease risk , 1994, Clinical genetics.
[51] C. Hammerman,et al. Neonatal screening for glucose-6-phosphate dehydrogenase deficiency: sex distribution. , 1994, Archives of disease in childhood. Fetal and neonatal edition.
[52] G. Brewer,et al. Treatment of Wilson's disease with zinc. XIII: Therapy with zinc in presymptomatic patients from the time of diagnosis. , 1994, The Journal of laboratory and clinical medicine.
[53] A. Hisashige. Health Economic Analysis of the Neonatal Screening Program in Japan , 1994, International Journal of Technology Assessment in Health Care.
[54] H. Vallance,et al. An improved method for quantification of very long chain fatty acids in plasma. , 1994, Clinical biochemistry.
[55] M. Silink,et al. Morbidity and mortality in medium chain acyl coenzyme A dehydrogenase deficiency. , 1994, Archives of disease in childhood.
[56] J. Opitz,et al. Cholesterol metabolism in the RSH/Smith-Lemli-Opitz syndrome: summary of an NICHD conference. , 1994, American journal of medical genetics.
[57] P. H. Thomas,et al. Presentation, acute illness, and learning difficulties in salt wasting 21-hydroxylase deficiency. , 1994, Archives of disease in childhood.
[58] P. Costello,et al. Outcome of treatment in young adults with phenylketonuria detected by routine neonatal screening between 1964 and 1971. , 1994, The Quarterly journal of medicine.
[59] R. Denmeade,et al. Neonatal Screening for Phenylketonuria: Evaluation of an Automated Enzymatic Method , 1994, Annals of clinical biochemistry.
[60] K. Pass,et al. A rapid fluorometric assay for newborn screening of α1-antitrypsin followed by phenotyping of deficient specimens by isoelectric focusing , 1994 .
[61] J. Travert,et al. Neonatal concentrations of apolipoproteins B and A-1 measured by radioimmunoassay in dried blood spots , 1994 .
[62] J. Vockley. The changing face of disorders of fatty acid oxidation. , 1994, Mayo Clinic proceedings.
[63] A. Green,et al. An improved thin layer chromatography technique for neonatal screening for amino acid disorders using dried blood spots , 1994 .
[64] M. Bennett,et al. Population Screening for Medium-Chain Acyl-CoA Dehydrogenase Deficiency: Analysis of Medium-Chain Fatty Acids and Acylglyeines in Blood Spots , 1994, Annals of clinical biochemistry.
[65] C. Kelnar. Congenital adrenal hyperplasia (CAH)--the place for prenatal treatment and neonatal screening. , 1993, Early human development.
[66] F. Eyskens,et al. Urinary Excretion of Purine and Pyrimidine Metabolites in the Neonate , 1993, Pediatric Research.
[67] V. Sardesai. Molybdenum: an essential trace element. , 1993, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[68] L. Ment,et al. Short‐term response to dietary therapy in molybdenum cofactor deficiency , 1993, Annals of neurology.
[69] W. Hummel,et al. Neonatal screening for maple syrup urine disease by an enzyme-mediated colorimetric method. , 1993, Clinica chimica acta; international journal of clinical chemistry.
[70] A. Matsui,et al. Neonatal mass screening for biliary atresia: A pilot study in Tochigi Prefecture, Japan , 1993 .
[71] T. Cowan,et al. Erythrocyte uridine diphosphate galactose-4- epimerase deficiency identified by newborn screening for galactosemia in the United States , 1993 .
[72] W. H. Hannon,et al. Description of quality assurance programs in newborn screening , 1993 .
[73] M. Irons,et al. Screening for metabolic disorders. How are we doing? , 1993, Pediatric clinics of North America.
[74] I. C. Smith,et al. Rapid automated enzymatic measurement of phenylalanine in plasma and blood spots. , 1993, Clinica chimica acta; international journal of clinical chemistry.
[75] J. Leonard,et al. Galactosaemia: results of the British Paediatric Surveillance Unit Study, 1988-90. , 1993, Archives of disease in childhood.
[76] H. J. Brink,et al. Diagnosis of peroxisomal disorders by analysis of phytanic and pristanic acids in stored blood spots collected at neonatal screening. , 1993, Clinical chemistry.
[77] B. Wilcken,et al. Neonatal symptoms in medium chain acyl coenzyme A dehydrogenase deficiency. , 1993, Archives of disease in childhood.
[78] J. Horne,et al. Cost-effectiveness of neonatal screening for Duchenne muscular dystrophy--how does this compare to existing neonatal screening for metabolic disorders? , 1993, Social science & medicine.
[79] P. Klein,et al. Effect of dietary cholesterol on cholesterol synthesis in breast-fed and formula-fed infants. , 1993, Journal of lipid research.
[80] S. Hiyamuta,et al. Early diagnosis of Wilson's disease , 1993, The Lancet.
[81] R. Pollitt,et al. Neonatal screening. , 1993, Journal of clinical pathology.
[82] A. Novello. Inherited metabolic diseases: collaborating for the health of all children. , 1993, Biochemical medicine and metabolic biology.
[83] C. Stanley,et al. Detection of inborn errors of fatty acid oxidation from acylcarnitine analysis of plasma and blood spots with the radioisotopic exchange-high-performance liquid chromatographic method. , 1993, The Journal of pediatrics.
[84] Y. T. Chen,et al. Medium-chain acyl-CoA dehydrogenase (MCAD) deficiency: diagnosis by acylcarnitine analysis in blood. , 1993, American journal of human genetics.
[85] E. C. Neto,et al. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder , 1993 .
[86] E. Paux,et al. Evaluation of an enzymatic, colorimetric method for the neonatal screening of phenylketonuria , 1993 .
[87] M. Gillman. Screening for familial hypercholesterolemia in childhood. , 1993, American journal of diseases of children.
[88] J. Frézal,et al. Results of pilot screening activities in the French neonatal screening program — cystic fibrosis, congenital adrenal hyperplasia and sickle cell disease , 1993 .
[89] J. Farriaux,et al. [Neonatal screening in France]. , 1993, Soins. Gynecologie, obstetrique, puericulture, pediatrie.
[90] M. Hutchinson,et al. An epidemiological study of Wilson's disease in the Republic of Ireland. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[91] David J. P. Barker. Fetal origins of coronary heart disease. , 1993, British heart journal.
[92] R. Surtees,et al. Phenylketonuria due to phenylalanine hydroxylase deficiency: an unfolding story. Medical Research Council Working Party on Phenylketonuria. , 1993, BMJ.
[93] D. Frazier,et al. Minimizing false positive diagnoses in newborn screening for galactosemia. , 1992, Biochemical medicine and metabolic biology.
[94] T. Tuuminen,et al. Kinetic fluorometric micromethod for screening of newborns for galactosemia--a way to improve assay specificity? , 1992, Clinica chimica acta; international journal of clinical chemistry.
[95] R. Taylor,et al. Phenylalanine: Application of a Simple HPLC Technique to its Measurement in Dried Blood Spots , 1992, Annals of clinical biochemistry.
[96] S. Lindstedt,et al. Neonatal screen for hereditary tyrosinaemia type I , 1992, The Lancet.
[97] E. Clayton. Issues in state newborn screening programs. , 1992, Pediatrics.
[98] B. Wolf,et al. Comparison of profound biotinidase deficiency in children ascertained clinically and by newborn screening using a simple method of accurately determining residual biotinidase activity. , 1992, Biochemical medicine and metabolic biology.
[99] M. Kotze,et al. DNA screening of hyperlipidemic Afrikaners for familial hypercholesterolemia , 1992, Clinical genetics.
[100] R. Chandra,et al. Conclusions, guidelines and recommendations from the IUNS/WHO Workshop: nutrition in the pediatric age group and later cardiovascular disease. , 1992, Journal of the American College of Nutrition.
[101] K. Widhalm,et al. Long-term follow-up of 12 patients with the late-onset variant of argininosuccinic acid lyase deficiency: no impairment of intellectual and psychomotor development during therapy. , 1992, Pediatrics.
[102] L. Friedman,et al. Wilson's disease: current status. , 1992, The American journal of medicine.
[103] T. Tuuminen. Changing of critical variables in the fluorometric microplate-based method for phenylketonuria screening. , 1992, Clinical chemistry.
[104] B. Wolf,et al. Biochemical and Immunologic Characterization of Serum Biotinidase in Partial Biotinidase , 1992, Pediatric Research.
[105] J. Sander,et al. Colorimetric determination of galactose and galactose-1-phosphate from dried blood. , 1992, Clinical biochemistry.
[106] L. Wright,et al. Newborn screening: the miracle and the challenge. , 1992, Journal of pediatric nursing.
[107] C. Charpentier,et al. Medium chain acyl-CoA dehydrogenase deficiency. , 1992, Archives of disease in childhood.
[108] D. Millington,et al. The analysis of diagnostic markers of genetic disorders in human blood and urine using tandem mass spectrometry with liquid secondary ion mass spectrometry , 1991 .
[109] E. de Hoffmann,et al. Bile acids and conjugates identified in metabolic disorders by fast atom bombardment and tandem mass spectrometry. , 1991, Clinical chemistry.
[110] I. Francis. Newborn screening in Australia and New Zealand 1984–1990 , 1991, The Medical journal of Australia.
[111] S. Brusilow,et al. Prospective treatment of urea cycle disorders. , 1991, The Journal of pediatrics.
[112] L. Bolund,et al. Specific diagnosis of medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in dried blood spots by a polymerase chain reaction (PCR) assay detecting a point-mutation (G985) in the MCAD gene. , 1991, Clinica chimica acta; international journal of clinical chemistry.
[113] P. E. Johnson,et al. Screening Newborns for Multiple Organic Acidurias in Dried Filter Paper Urine Samples: Method Development , 1991, Pediatric Research.
[114] D. Danks,et al. Prevalence of K329E mutation in medium-chain acyl-CoA dehydrogenase gene determined from Guthrie cards , 1991, The Lancet.
[115] D. Elliman,et al. Review of neonatal screening programme for phenylketonuria. , 1991, BMJ.
[116] S. Larsen,et al. Screening for familial hypercholesterolaemia by measurement of apolipoproteins in capillary blood. , 1991, Archives of disease in childhood.
[117] D. Danks,et al. The natural history of untreated phenylketonuria over 20 years , 1991, Journal of paediatrics and child health.
[118] T. Declue,et al. Florida newborn screening for galactosemia. , 1991, The Journal of the Florida Medical Association.
[119] J. Lloyd. Cholesterol: Should We Screen All Children or Change the Diet of All Children , 1991, Acta paediatrica Scandinavica. Supplement.
[120] J. Wu. Screening for inborn errors of amino acid metabolism. , 1991, Annals of clinical and laboratory science.
[121] Glenn O. Brown,et al. Carnitine in dried blood spots: a method suitable for neonatal screening. , 1991, Clinica chimica acta; international journal of clinical chemistry.
[122] F. Rohr,et al. Detection of phenylketonuria in the very early newborn blood specimen. , 1991, Pediatrics.
[123] W. Hummel,et al. A new approach to the newborn screening for hyperphenylalaninemias: use of L-phenylalanine dehydrogenase and microtiter plates. , 1990, Clinica chimica acta; international journal of clinical chemistry.
[124] P. Kwiterovich. Diagnosis and management of familial dyslipoproteinemia in children and adolescents. , 1990, Pediatric clinics of North America.
[125] M. Seashore. Neonatal screening for inborn errors of metabolism: update. , 1990, Seminars in perinatology.
[126] C. Mabry. Phenylketonuria: contemporary screening and diagnosis. , 1990, Annals of clinical and laboratory science.
[127] D. Wilcken,et al. Neonatal apo A-I, apo B, and apo(a) Levels in Dried Blood Spots in an Australian Population , 1990, Pediatric Research.
[128] J. Morissette,et al. Fumarylacetoacetase measurement as a mass-screening procedure for hereditary tyrosinemia type I. , 1990, American journal of human genetics.
[129] H. Hobbs,et al. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. , 1990, Annual review of genetics.
[130] A. Ades,et al. Intelligence and quality of dietary treatment in phenylketonuria. , 1990, Archives of disease in childhood.
[131] B. Wolf,et al. Screening for biotinidase deficiency in newborns: worldwide experience. , 1990, Pediatrics.
[132] L. Vilarinho,et al. Assessment of a trial screening program for congenital adrenal hyperplasia in Portugal based on an antibody-coated tube RIA for 17 alpha-OH-progesterone. , 1989, Clinical chemistry.
[133] D M Eddy,et al. Selecting Technologies for Assessment , 1989, International Journal of Technology Assessment in Health Care.
[134] N. Gerasimova,et al. Fluorometric method for phenylalanine microplate assay adapted for phenylketonuria screening. , 1989, Clinical chemistry.
[135] R. Chalmers,et al. Characterization of acylcarnitines as their isobutyl ester derivatives using fast atom bombardment mass spectrometry and constant neutral loss scan , 1989 .
[136] L. Kalaydjieva,et al. Avoiding sources of error in PKU screening. , 1989, American journal of clinical pathology.
[137] D. Millington,et al. Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, blood, and tissue. , 1989, Analytical biochemistry.
[138] D. A. Pettit,et al. The quantitation of biotinidase activity in dried blood spots using microtiter transfer plates: identification of biotinidase-deficient and heterozygous individuals. , 1989, Analytical biochemistry.
[139] D. Wilcken,et al. Enzyme-linked immunosorbent assay of apolipoprotein B in blood spotted onto filter paper, suitable for neonatal screening. , 1989, Clinical chemistry.
[140] A. Munnich,et al. Clinical approach to inherited metabolic diseases in the neonatal period: A 20-year survey , 1989, Journal of Inherited Metabolic Disease.
[141] H. Mabuchi,et al. Development of coronary heart disease in familial hypercholesterolemia. , 1989, Circulation.
[142] M. Polichroniadis. Parental understanding and attitudes towards neonatal biochemical screening. , 1989, Midwives chronicle.
[143] B. No̸rgaard-Pedersen,et al. Simultaneous quantification by double rocket immunoelectrophoresis of apolipoproteins A-I and B in blood spotted on filter paper. , 1988, Clinical chemistry.
[144] K. Aoki,et al. Outcome of the Patients Detected by Newborn Screening in Japan , 1988, Acta paediatrica Japonica : Overseas edition.
[145] M. Migita,et al. Enzyme-linked immunosorbent assay for apolipoprotein B on dried blood spot derived from newborn infant: its application to neonatal mass screening for hypercholesterolemia. , 1988, Journal of pediatric gastroenterology and nutrition.
[146] A. Clague,et al. Neonatal screening and an intensive management programme for galactosaemia: early evidence of benefits , 1988, The Medical journal of Australia.
[147] H. Savithri,et al. Neonatal screening for amino acidaemias in Karnataka, South India , 1988, Clinical genetics.
[148] T. E. Stacey,et al. Urinary C6-C12 dicarboxylic acylcarnitines in Reye's syndrome. , 1988, Clinica chimica acta; international journal of clinical chemistry.
[149] K. Fujieda,et al. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. , 1988, Pediatrics.
[150] D. Wilcken,et al. Screening for Familial Hypercholesterolemia in 5000 Neonates: A Recall Study , 1988, Pediatric Research.
[151] KARIN FYRÖ,et al. Neonatal Screening: Life‐Stress Scores in Families Given a False‐Positive Result , 1988, Acta paediatrica Scandinavica.
[152] S. Heyerdahl. Psychological Problems in Relation to Neonatal Screening Programmes , 1988, Acta paediatrica Scandinavica.
[153] G. Bodegård,et al. Difficulties in Psychological Adjustment to a New Neonatal Screening Programme , 1988, Acta paediatrica Scandinavica.
[154] T. Hansen,et al. Galactosemia--to screen or not to screen? , 1988, Pediatrics.
[155] D. Maltby,et al. Characterization of new diagnostic acylcarnitines in patients with beta-ketothiolase deficiency and glutaric aciduria type I using mass spectrometry. , 1987, Biomedical & environmental mass spectrometry.
[156] C. Tiwary. Neonatal screening for metabolic and endocrine diseases. , 1987, The Nurse practitioner.
[157] I. Björkhem,et al. Diagnosis of Zellweger syndrome by analysis of bile acids and plasmalogens in stored dried blood collected at neonatal screening. , 1987, The Journal of pediatrics.
[158] C. Fitzpatrick,et al. NEONATAL SCREENING FOR HYPERCHOLESTEROLAEMIA , 1987, The Lancet.
[159] D. C. Jinks,et al. A fluorometric micromethod for estimation of carnosinase in dried blood samples. , 1987, Clinica chimica acta; international journal of clinical chemistry.
[160] A. Green,et al. Should we screen for congenital adrenal hyperplasia? A review of 117 cases. , 1987, Archives of disease in childhood.
[161] D. Wilcken,et al. Variables Affecting Apolipoprotein B Measurements in 3- to 5-Day-Old Babies: A Study of 4491 Neonates , 1987, Pediatric Research.
[162] H. Nishio,et al. A simple method to diagnose adrenoleukodystrophy using a dried blood spot on filter paper. , 1986, Clinica chimica acta; international journal of clinical chemistry.
[163] G. Nyberg,et al. Children with Inborn Errors of Phenylalanine Metabolism: Prognosis and Phenylalanine Tolerance , 1986, Acta paediatrica Scandinavica.
[164] E. Vartiainen,et al. Effects of Dietary Fat Modifications on Serum Lipids and Blood Pressure in Children , 1986, Acta paediatrica Scandinavica.
[165] D. Maltby,et al. Identification of 3-methylglutarylcarnitine. A new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency. , 1986, The Journal of clinical investigation.
[166] G. Beastall,et al. Neonatal screening for congenital adrenal hyperplasia: a programme based on a novel direct radioimmunoassay for 17-hydroxyprogesterone in blood spots. , 1986, The Journal of endocrinology.
[167] F. Bernardi,et al. Neonatal Screening Program for Congenital Adrenal Hyperplasia in a Homogeneous Caucasian Population , 1985, Annals of the New York Academy of Sciences.
[168] K. Morgan,et al. Screening for methylmalonic aciduria in Alberta: a voluntary program with particular significance for the Hutterite Brethren. , 1985, American journal of medical genetics.
[169] J. R. Simmons,et al. Stability of amino acids and galactose in the newborn screening filter paper blood specimen. , 1985, The Journal of pediatrics.
[170] M. Irie,et al. Neonatal Screening for Congenital Adrenal Hyperplasia in Japan , 1985, Annals of the New York Academy of Sciences.
[171] C. Sansaricq,et al. Newborn screening for maple syrup urine disease. , 1985, The Journal of pediatrics.
[172] D. Wilcken,et al. Radial immunodiffusion assay of apolipoprotein B in blood dried on filter paper--a potential screening method for familial type II hypercholesterolaemia. , 1985, Clinica chimica acta; international journal of clinical chemistry.
[173] A. Giagheddu,et al. Epidemiologic study of hepatolenticular degeneration (Wilson's disease) in Sardinia (1902–1983) , 1985, Acta neurologica Scandinavica.
[174] L. Hofman,et al. Direct solid-phase radioimmunoassay for screening 17 alpha-hydroxyprogesterone in whole-blood samples from newborns. , 1985, Clinical chemistry.
[175] T. Bohan,et al. Diagnostic and Therapeutic Implications of Medium-Chain Acylcarnitines in the Medium-Chain Acyl-CoA Dehydrogenase Deficiency , 1985, Pediatric Research.
[176] D. Hardwick,et al. Screening of newborn infants for galactosemia in British Columbia. , 1985, Canadian Medical Association journal.
[177] E. Naylor. Recent developments in neonatal screening. , 1985, Seminars in perinatology.
[178] T. Bohan,et al. L-carnitine therapy in isovaleric acidemia. , 1984, The Journal of clinical investigation.
[179] R. Chalmers,et al. Urinary Excretion of l-Carnitine and Acylcarnitines by Patients with Disorders of Organic Acid Metabolism: Evidence for Secondary Insufficiency of l-Carnitine , 1984, Pediatric Research.
[180] H. Levy,et al. Massachusetts Metabolic Disorders Screening Program: III. Sarcosinemia. , 1984, Pediatrics.
[181] S. Brusilow,et al. Neurologic outcome in children with inborn errors of urea synthesis. Outcome of urea-cycle enzymopathies. , 1984, The New England journal of medicine.
[182] D. Kenny,et al. Failure of cord serum cholesterol and betalipoprotein as screening tests for familial hyperlipoproteinaemia , 1984, Irish journal of medical science.
[183] C. Hoppel,et al. Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups. , 1983, Archives of disease in childhood.
[184] T. Asami. SCREENING FOR HYPERCHOLESTEROLAEMIA ON BLOOD-SPOTTED FILTERPAPER , 1983, The Lancet.
[185] S. Pagliardini,et al. GUTHRIE TEST RECALLS DUE TO ANTIBIOTIC INHIBITION , 1983, The Lancet.
[186] K. Blau. Determination of phenylalanine in filter paper blood spots by a simplified automated fluorimetric method without dialysis. , 1983, Clinica chimica acta; international journal of clinical chemistry.
[187] D. Wilcken,et al. Increased plasma copper in patients with homocystinuria due to cystathionine beta-synthase deficiency. , 1983, Clinica chimica acta; international journal of clinical chemistry.
[188] J. Leonard,et al. Outcome of maple syrup urine disease. , 1982, Archives of disease in childhood.
[189] H. Kirkman,et al. Fifteen-year experience with screening for phenylketonuria with an automated fluorometric method. , 1982, American journal of human genetics.
[190] K. Paigen,et al. A new method of screening for inherited disorders of galactose metabolism. , 1982, The Journal of laboratory and clinical medicine.
[191] M. Rosseneu,et al. A screening procedure for dyslipoproteinemia in the newborn. Apoprotein quantitation on dried blood spots. , 1982, Clinica chimica acta; international journal of clinical chemistry.
[192] U. Rosenqvist,et al. Health Economic Analysis of the Swedish Neonatal Metabolic Screening Programme , 1982, Medical decision making : an international journal of the Society for Medical Decision Making.
[193] T. Saito. An assessment of efficiency in potential screening for Wilson's disease. , 1981, Journal of epidemiology and community health.
[194] I. Smith,et al. Hyperphenylalaninaemia of various types among three-quarters of a million neonates tested in a screening programme. , 1981, Archives of disease in childhood.
[195] E. Naylor. Newborn screening for urea cycle disorders. , 1981, Advances in experimental medicine and biology.
[196] A. Larsson,et al. EVALUATION OF A NATION‐WIDE NEONATAL METABOLIC SCREENING PROGRAMME IN SWEDEN 1965–1979 , 1981, Acta paediatrica Scandinavica.
[197] S. Snyderman. Clinical aspects of disorders of the urea cycle. , 1981, Pediatrics.
[198] Routine neonatal screening for phenylketonuria in the United Kingdom 1964-78. Medical Research Council Steering Committee for the MRC/DHSS Phenylketonuria Register. , 1981, British medical journal.
[199] F. Schaffner,et al. Hypermethioninemia associated with methionine adenosyltransferase deficiency: clinical, morphologic, and biochemical observations on four patients. , 1981, The Journal of pediatrics.
[200] D. Meryash,et al. Prospective study of early neonatal screening for phenylketonuria. , 1981, The New England journal of medicine.
[201] H. Levy,et al. Massachusetts Metabolic Disorders Screening Program. II. Methylmalonic aciduria. , 1981, Pediatrics.
[202] M. Andreoli,et al. Neonatal screening in Italy for congenital hypothyroidism and metabolic disorders: hyperphenylalaninemia, maple syrup urine disease and homocystinuria , 1980, Journal of endocrinological investigation.
[203] B. Wilcken,et al. Urine screening for aminoacidopathies: is it beneficial? Results of a long-term follow-up of cases detected bny screening one millon babies. , 1980, The Journal of pediatrics.
[204] J. Sibert,et al. Congenital adrenal hyperplasia--a clinical and genetic survey. Are we detecting male salt-losers? , 1980, Archives of disease in childhood.
[205] G. Komrower,et al. The Manchester regional screening programme: a 10-year exercise in patient and family care. , 1979, British medical journal.
[206] B. Friis‐Hansen,et al. SCREENING FOR HYPERLIPOPROTEINEMIA IN 10 000 DANISH NEWBORNS Follow‐up Studies in 522 Children with Elevated Cord Serum VLDL‐LDL‐Cholesterol , 1979, Acta paediatrica Scandinavica.
[207] Sydney,et al. Childhood cystinuria in New South Wales. Results in children who were followed up after being detected by urinary screening in infancy. , 1979, Archives of disease in childhood.
[208] G. E. Andersen,et al. Familial hypobetalipoproteinaemia in 9 children diagnosed as the result of cord blood screening for hypolipoproteinaemia in 10 000 Danish newborns. , 1979, Archives of disease in childhood.
[209] B. Clayton,et al. Changing incidence of neonatal hypermethioninaemia: implications for the detection of homocystinuria. , 1979, Archives of disease in childhood.
[210] I. H. Craig,et al. SCREENING OF CORD BLOOD LOW‐DENSITY‐LIPOPROTEIN CHOLESTEROL IN THE DIAGNOSIS OF FAMILIAL HYPERCHOLESTEROLAEMIA: A STUDY OF 2000 INFANTS , 1979, Acta paediatrica Scandinavica.
[211] H. Levy,et al. Newborn screening for galactosemia and other galactose metabolic defects. , 1978, The Journal of pediatrics.
[212] R. Grover,et al. Evaluation of the expanded newborn screening program in New York City. , 1978, Pediatrics.
[213] M. Nakahashi,et al. NEW SCREENING METHOD FOR WILSON'S DISEASE AND MENKES' KINKY-HAIR DISEASE , 1977, The Lancet.
[214] G. Vawter,et al. Sepsis due to Escherichia coli in neonates with galactosemia. , 1977, The New England journal of medicine.
[215] W. Zaleski,et al. Difficulties and pitfalls in the interpretation of screening tests for the detection of inborn errors of metabolism. , 1976, Clinica chimica acta; international journal of clinical chemistry.
[216] B. Friis‐Hansen,et al. Neonatal diagnosis of familial type II hyperlipoproteinemia. , 1976, Pediatrics.
[217] C. Chapman,et al. Galactosaemia: Estimated live birth incidence in New Zealand , 1975, Human Genetics.
[218] C. Laurell,et al. Mass screening of newborn Swedish infants for alpha antitrypsin deficiency. , 1975, American journal of human genetics.
[219] COLLECTIVE RESULTS OF MASS SCREENING FOR INBORN METABOLIC ERRORS IN EIGHT EUROPEAN COUNTRIES , 1973, Acta paediatrica Scandinavica.
[220] J. Sabater,et al. Mass screening newborns for mucopolysaccharidoses , 1973, Clinical genetics.
[221] J. Holton. Large-scale investigation of 2 phenylketonuria screening methods and factors affecting blood phenylalanine levels in the newborn. , 1973, Archives of disease in childhood.
[222] R. Levy,et al. Neonatal diagnosis of familial type-II hyperlipoproteinaemia. , 1973, Lancet.
[223] W. N. Kelley,et al. Hypoxanthine-guanine phosphoribosyltransferase deficiency in the Lesch-Nyhan syndrome and gout. , 1968, Federation proceedings.
[224] D. Mathias,et al. QUALITY CONTROL IN NEONATAL SCREENING FOR INBORN ERRORS OF METABOLISM , 1998 .
[225] P. Farrell,et al. Newborn screening: principles and practice. , 1996, Advances in pediatrics.
[226] M. Tsuda. [Disorders of organic acid metabolism]. , 1996, Ryoikibetsu shokogun shirizu.
[227] W. Cutfield,et al. Newborn screening for congenital adrenal hyperplasia in New Zealand. , 1995, The Journal of pediatrics.
[228] J. Christodoulou,et al. Neonatal onset of medium-chain acyl-coenzyme A dehydrogenase deficiency with confusing biochemical features. , 1995, The Journal of pediatrics.
[229] E. R. Baumgarter,et al. Long-term follow-up of 77 patients with isolated methylmalonic acidaemia. , 1995, Journal of inherited metabolic disease.
[230] P. Macfarlane,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.
[231] D. Millington,et al. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry. , 1995, Clinical chemistry.
[232] H. Bremer,et al. Selective screening for inborn errors of metabolism , 1994 .
[233] J. Sander,et al. Phenylketonuria Screening with a Fluorometric Microplate Assay , 1994, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[234] M. E. Harrison,et al. Electrospray tandem mass spectrometry in the diagnosis of organic acidemias , 1994 .
[235] Joanne M. Meyer,et al. Comparison of the effects of season and prematurity on the enzymatic newborn screening tests for galactosemia and biotinidase deficiency , 1993 .
[236] T. Laskowska-Klita,et al. Twenty-five years experience with newborn screening for phenylketonuria (PKU) in Poland , 1993 .
[237] J. Sander,et al. New neonatal thyrotropin enzyme immunoassay with fluorimetric detection: comparison with time-resolved fluoroimmunoassay. , 1993, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[238] D. Millington,et al. Rapid diagnosis of phenylketonuria by quantitative analysis for phenylalanine and tyrosine in neonatal blood spots by tandem mass spectrometry. , 1993, Clinical chemistry.
[239] C. Keller,et al. Metabolic screening in the NICU population: a proposal for change. , 1993, Pediatric nursing.
[240] B. No̸rgaard-Pedersen. Prenatal and neonatal screening: status and future trends. , 1992, Scandinavian journal of infectious diseases. Supplementum.
[241] A. Cicognani,et al. The experience of neonatal screening for congenital adrenal hyperplasia. , 1992, Hormone research.
[242] A. Blakemore,et al. Medium chain acyl-CoA dehydrogenase deficiency in the United Kingdom. , 1992, Progress in clinical and biological research.
[243] Y. T. Chen,et al. The role of tandem mass spectrometry in the diagnosis of fatty acid oxidation disorders. , 1992, Progress in clinical and biological research.
[244] I. Durand-zaleski,et al. Inborn Errors of Amino Acid Metabolism: The Best Strategy for Their Diagnosis , 1992, International Journal of Technology Assessment in Health Care.
[245] M. O'Flynn. Newborn screening for phenylketonuria: thirty years of progress. , 1992, Current problems in pediatrics.
[246] P. Clemens,et al. Newborn screening for hyperphenylalaninemia on day 5: is 240 mumol/liter the most appropriate cut-off level? , 1990, Preventive medicine.
[247] M. Blitzer,et al. Partial biotinidase deficiency: clinical and biochemical features. , 1990, The Journal of pediatrics.
[248] E. Stein. Treatment of familial hypercholesterolemia with drugs in children. , 1989, Arteriosclerosis.
[249] I. Smith,et al. Intelligence and behaviour in children with early treated phenylketonuria. A report from the MRC/DHSS phenylketonuria register. , 1989, European journal of clinical nutrition.
[250] H. Bickel. Early diagnosis and treatment of inborn errors of metabolism. , 1987, Enzyme.
[251] W. Nance,et al. Neonatal screening for biotinidase deficiency: results of a 1-year pilot study. , 1986, The Journal of pediatrics.
[252] K. Méhes,et al. Chromatographic screening of 70,328 neonates for inborn errors of amino acid metabolism. , 1985, Acta paediatrica Hungarica.
[253] M. Mate,et al. Experience based on 800,000 newborn screening tests of the Budapest Phenylketonuria Centre. , 1985, Acta paediatrica Hungarica.
[254] K. Pettigrew,et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. , 1985, American journal of human genetics.
[255] H. Bickel. Differential diagnosis and treatment of hyperphenylalaninaemia. , 1985, Progress in clinical and biological research.
[256] L. Courville,et al. A cost-benefit analysis of the Quebec Network of Genetic Medicine. , 1985, Social science & medicine.
[257] Scriver Cr. Population screening: report of a workshop. , 1985, Progress in clinical and biological research.
[258] H. Barden,et al. The costs and benefits of screening for PKU in Wisconsin. , 1984, Social biology.
[259] N. Holtzman. Pitfalls of newborn screening (with special attention to hypothyroidism): when will we ever learn? , 1983, Birth defects original article series.
[260] F. Bernardi,et al. Neonatal screening for congenital adrenal hyperplasia using a microfilter paper method for 17-alpha-hydroxyprogesterone radioimmunoassay. Experience gained from the study of 22,233 cases. , 1982, Hormone research.
[261] E. Naylor,et al. Newborn screening for maple syrup urine disease (branched-chain ketoaciduria). , 1978, Pediatrics.
[262] P. Kwiterovich. Neonatal screening for hyperlipidemia. , 1974, Pediatrics.
[263] Massachusetts Department of Public Health. Cost-benefit analysis of newborn screening for metabolic disorders. , 1974, The New England journal of medicine.
[264] E. Kang,et al. Excess of males among false-positive tests on screening for phenylketonuria. , 1970, The New England journal of medicine.